Kiadis Pharma NV (XAMS:KDS) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Kiadis Pharma NV's net issuance of preferred for the six months ended in Dec. 2020 was €0.00 Mil. The number is 0, which means that Kiadis Pharma NV has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Kiadis Pharma NV's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2020 was €0.00 Mil.

Kiadis Pharma NV Net Issuance of Preferred Stock Historical Data

The historical data trend for Kiadis Pharma NV's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Net Issuance of Preferred Stock Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Net Issuance of Preferred Stock	Get a 7-Day Free Trial											-	-	-	-	-

Kiadis Pharma NV Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Kiadis Pharma NV Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (XAMS:KDS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (XAMS:KDS) Headlines

No Headlines